{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T17:19:17Z","timestamp":1787678357083,"version":"build-2784847793"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,9,16]],"date-time":"2024-09-16T00:00:00Z","timestamp":1726444800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,9,16]],"date-time":"2024-09-16T00:00:00Z","timestamp":1726444800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["21K09509"],"award-info":[{"award-number":["21K09509"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["21K09532"],"award-info":[{"award-number":["21K09532"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-024-72938-3","type":"journal-article","created":{"date-parts":[[2024,9,16]],"date-time":"2024-09-16T07:02:33Z","timestamp":1726470153000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Profiling of metabolic dysregulation in ovarian cancer tissues and biofluids"],"prefix":"10.1038","volume":"14","author":[{"given":"Tsuyoshi","family":"Ohta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiro","family":"Sugimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasufumi","family":"Ito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shota","family":"Horikawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yosuke","family":"Okui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirotsugu","family":"Sakaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manabu","family":"Seino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makoto","family":"Sunamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoru","family":"Nagase","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,9,16]]},"reference":[{"issue":"5","key":"72938_CR1","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","volume":"144","author":"D Hanahan","year":"2011","unstructured":"Hanahan, D. & Weinberg, R. A. Hallmarks of cancer: The next generation. Cell144(5), 646\u2013674. https:\/\/doi.org\/10.1016\/j.cell.2011.02.013 (2011).","journal-title":"Cell"},{"issue":"5","key":"72938_CR2","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/j.cmet.2012.09.013","volume":"16","author":"DI Benjamin","year":"2012","unstructured":"Benjamin, D. I., Cravatt, B. F. & Nomura, D. K. Global profiling strategies for mapping dysregulated metabolic pathways in cancer. Cell Metab.16(5), 565\u2013577. https:\/\/doi.org\/10.1016\/j.cmet.2012.09.013 (2012).","journal-title":"Cell Metab."},{"issue":"6","key":"72938_CR3","doi-asserted-by":"publisher","first-page":"1957","DOI":"10.1093\/bib\/bbx170","volume":"20","author":"RK Azad","year":"2019","unstructured":"Azad, R. K. & Shulaev, V. Metabolomics technology and bioinformatics for precision medicine. Brief. Bioinform. 20(6), 1957\u20131971. https:\/\/doi.org\/10.1093\/bib\/bbx170 (2019). PMID: 29304189; PMCID: PMC6954408.","journal-title":"Brief. Bioinform"},{"issue":"3","key":"72938_CR4","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1002\/mas.21548","volume":"38","author":"M Jacob","year":"2019","unstructured":"Jacob, M., Lopata, A. L., Dasouki, M. & Abdel Rahman, A. M. Metabolomics toward personalized medicine. Mass Spectrom Rev.38(3), 221\u2013238. https:\/\/doi.org\/10.1002\/mas.21548 (2019).","journal-title":"Mass Spectrom Rev."},{"issue":"2","key":"72938_CR5","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1093\/bib\/bbl012","volume":"7","author":"V Shulaev","year":"2006","unstructured":"Shulaev, V. Metabolomics technology and bioinformatics. Brief. Bioinform.7(2), 128\u2013139. https:\/\/doi.org\/10.1093\/bib\/bbl012 (2006).","journal-title":"Brief. Bioinform."},{"issue":"410","key":"72938_CR6","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1093\/jxb\/eri069","volume":"56","author":"JM Halket","year":"2005","unstructured":"Halket, J. M. et al. Chemical derivatization and mass spectral libraries in metabolic profiling by GC\/MS and LC\/MS\/MS. J. Exp. Bot.56(410), 219\u2013243. https:\/\/doi.org\/10.1093\/jxb\/eri069 (2005). Epub 2004 Dec 23. PMID: 15618298.","journal-title":"J. Exp. Bot."},{"key":"72938_CR7","unstructured":"The Surveillance. Epidemiology, and End Results (SEER) Program. https:\/\/seer.cancer.gov\/statfacts\/html\/ovary.html (2023-05-29)."},{"issue":"6","key":"72938_CR8","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1001\/jama.2017.21421","volume":"319","author":"JT Henderson","year":"2018","unstructured":"Henderson, J. T., Webber, E. M. & Sawaya, G. F. Screening for ovarian cancer: Updated evidence report and systematic review for the US preventive services task force. JAMA.319(6), 595\u2013606. https:\/\/doi.org\/10.1001\/jama.2017.21421 (2018).","journal-title":"JAMA."},{"issue":"4","key":"72938_CR9","doi-asserted-by":"publisher","first-page":"913","DOI":"10.3390\/cancers13040913","volume":"13","author":"JF Fahrmann","year":"2021","unstructured":"Fahrmann, J. F. et al. A MYC-Driven plasma polyamine signature for early detection of Ovarian Cancer. Cancers (Basel). 13(4), 913. https:\/\/doi.org\/10.3390\/cancers13040913 (2021). PMID: 33671595; PMCID: PMC7927060.","journal-title":"Cancers (Basel)"},{"key":"72938_CR10","doi-asserted-by":"crossref","unstructured":"Ke, C. et al. Large-scale profiling of metabolic dysregulation in ovarian cancer. Int J Cancer. ;136(3):516\u2009\u2013\u200926. doi: 10.1002\/ijc.29010. Epub 2014 Jun 17. PMID: 24895217. (2015).","DOI":"10.1002\/ijc.29010"},{"issue":"8","key":"72938_CR11","doi-asserted-by":"publisher","first-page":"2081","DOI":"10.1158\/1078-0432.CCR-16-1647","volume":"23","author":"A Bachmayr-Heyda","year":"2017","unstructured":"Bachmayr-Heyda, A. et al. Integrative systemic and local metabolomics with impact on survival in high-grade serous ovarian cancer. Clin. Cancer Res.23(8), 2081\u20132092. https:\/\/doi.org\/10.1158\/1078-0432.CCR-16-1647 (2017).","journal-title":"Clin. Cancer Res."},{"issue":"1","key":"72938_CR12","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.ygyno.2015.10.021","volume":"140","author":"MF Buas","year":"2016","unstructured":"Buas, M. F. et al. Identification of novel candidate plasma metabolite biomarkers for distinguishing serous ovarian carcinoma and benign serous ovarian tumors. Gynecol. Oncol.140(1), 138\u2013144. https:\/\/doi.org\/10.1016\/j.ygyno.2015.10.021 (2016). Epub 2015 Oct 30. PMID: 26521694; PMCID: PMC5310763.","journal-title":"Gynecol. Oncol."},{"issue":"7","key":"72938_CR13","doi-asserted-by":"publisher","first-page":"1360","DOI":"10.1097\/IGC.0000000000001031","volume":"27","author":"RJ Niemi","year":"2017","unstructured":"Niemi, R. J. et al. Urinary polyamines as biomarkers for ovarian cancer. Int. J. Gynecol. Cancer.27(7), 1360\u20131366. https:\/\/doi.org\/10.1097\/IGC.0000000000001031 (2017).","journal-title":"Int. J. Gynecol. Cancer."},{"issue":"23","key":"72938_CR14","doi-asserted-by":"publisher","first-page":"5835","DOI":"10.1158\/1078-0432.CCR-10-1434","volume":"16","author":"CM Slupsky","year":"2010","unstructured":"Slupsky, C. M. et al. Urine metabolite analysis offers potential early diagnosis of ovarian and breast cancers. Clin. Cancer Res.16(23), 5835\u20135841. https:\/\/doi.org\/10.1158\/1078-0432.CCR-10-1434 (2010). Epub 2010 Oct 18. PMID: 20956617.","journal-title":"Clin. Cancer Res."},{"key":"72938_CR15","doi-asserted-by":"publisher","first-page":"10795","DOI":"10.1158\/0008-5472.CAN-06-0755","volume":"66","author":"C Denkert","year":"2006","unstructured":"Denkert, C. et al. Mass spectrometry-based metabolic profiling reveals different metabolite patterns in invasive ovarian carcinomas and ovarian borderline tumors. Cancer Res.66, 10795\u201310804. https:\/\/doi.org\/10.1158\/0008-5472.CAN-06-0755 (2006).","journal-title":"Cancer Res."},{"key":"72938_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0019963","volume":"6","author":"MY Fong","year":"2011","unstructured":"Fong, M. Y., McDunn, J. & Kakar, S. S. Identification of metabolites in the normal ovary and their transformation in primary and metastatic ovarian cancer. PLoS One. 6, 1\u201312. https:\/\/doi.org\/10.1371\/journal.pone.0019963 (2011).","journal-title":"PLoS One"},{"issue":"1","key":"72938_CR17","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1186\/s12935-021-02014-7","volume":"21","author":"K Yoshida","year":"2021","unstructured":"Yoshida, K. et al. Metabolome analysis reveals a diversity of cancer tissues in advanced epithelial ovarian cancer. Cancer Cell. Int.21(1), 314. https:\/\/doi.org\/10.1186\/s12935-021-02014-7 (2021). PMID: 34134729; PMCID: PMC8207638.","journal-title":"Cancer Cell. Int."},{"issue":"3","key":"72938_CR18","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1007\/s10549-019-05330-9","volume":"177","author":"T Murata","year":"2019","unstructured":"Murata, T. et al. Salivary metabolomics with alternative decision tree-based machine learning methods for breast cancer discrimination. Breast Cancer Res. Treat.177(3), 591\u2013601. https:\/\/doi.org\/10.1007\/s10549-019-05330-9 (2019). Epub 2019 Jul 8. PMID: 31286302.","journal-title":"Breast Cancer Res. Treat."},{"issue":"2","key":"72938_CR19","doi-asserted-by":"publisher","first-page":"43","DOI":"10.3390\/cancers10020043","volume":"10","author":"Y Asai","year":"2018","unstructured":"Asai, Y. et al. Elevated polyamines in saliva of pancreatic cancer. Cancers (Basel)10(2), 43. https:\/\/doi.org\/10.3390\/cancers10020043 (2018).","journal-title":"Cancers (Basel)"},{"key":"72938_CR20","doi-asserted-by":"publisher","first-page":"31520","DOI":"10.1038\/srep31520","volume":"6","author":"S Ishikawa","year":"2016","unstructured":"Ishikawa, S. et al. Identification of salivary metabolomic biomarkers for oral cancer screening. Sci. Rep.6, 31520. https:\/\/doi.org\/10.1038\/srep31520 (2016). PMID: 27539254; PMCID: PMC4990923.","journal-title":"Sci. Rep."},{"issue":"37","key":"72938_CR21","doi-asserted-by":"publisher","first-page":"E7697","DOI":"10.1073\/pnas.1710366114","volume":"114","author":"K Satoh","year":"2017","unstructured":"Satoh, K. et al. Global metabolic reprogramming of colorectal cancer occurs at adenoma stage and is induced by MYC. Proc. Natl. Acad. Sci. USA114(37), E7697\u2013E7706. https:\/\/doi.org\/10.1073\/pnas.1710366114 (2017).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"5","key":"72938_CR22","doi-asserted-by":"publisher","first-page":"e19963","DOI":"10.1371\/journal.pone.0019963","volume":"6","author":"MY Fong","year":"2011","unstructured":"Fong, M. Y., McDunn, J. & Kakar, S. S. Identification of metabolites in the normal ovary and their transformation in primary and metastatic ovarian cancer. PLoS One. 6(5), e19963. https:\/\/doi.org\/10.1371\/journal.pone.0019963 (2011). Epub 2011 May 19. PMID: 21625518; PMCID: PMC3098284.","journal-title":"PLoS One"},{"issue":"7","key":"72938_CR23","doi-asserted-by":"publisher","first-page":"2092","DOI":"10.3390\/ijms19072092","volume":"19","author":"A Rizzo","year":"2018","unstructured":"Rizzo, A. et al. One-carbon metabolism: Biological players in epithelial ovarian cancer. Int. J. Mol. Sci.19(7), 2092. https:\/\/doi.org\/10.3390\/ijms19072092 (2018).","journal-title":"Int. J. Mol. Sci."},{"issue":"10","key":"72938_CR24","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1038\/s41568-018-0054-z","volume":"18","author":"R Keshet","year":"2018","unstructured":"Keshet, R., Szlosarek, P., Carracedo, A. & Erez, A. Rewiring urea cycle metabolism in cancer to support anabolism. Nat Rev Cancer.18(10), 634\u2013645. https:\/\/doi.org\/10.1038\/s41568-018-0054-z (2018).","journal-title":"Nat Rev Cancer."},{"issue":"19","key":"72938_CR25","doi-asserted-by":"publisher","first-page":"2937","DOI":"10.1042\/BCJ20160383","volume":"473","author":"TR Murray-Stewart","year":"2016","unstructured":"Murray-Stewart, T. R., Woster, P. M. & Casero, R. A. Jr Targeting polyamine metabolism for cancer therapy and prevention. Biochem. J.473(19), 2937\u20132953. https:\/\/doi.org\/10.1042\/BCJ20160383 (2016). PMID: 27679855; PMCID: PMC5711482.","journal-title":"Biochem. J."},{"issue":"10","key":"72938_CR26","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1038\/nrc1454","volume":"4","author":"EW Gerner","year":"2004","unstructured":"Gerner, E. W. & Meyskens, F. L. Jr. Polyamines and cancer: old molecules, new understanding. Nat Rev Cancer.4(10), 781\u201392. https:\/\/doi.org\/10.1038\/nrc1454 (2004).","journal-title":"Nat Rev Cancer."},{"issue":"6","key":"72938_CR27","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1093\/jnci\/djz182","volume":"112","author":"JF Fahrmann","year":"2020","unstructured":"Fahrmann, J. F. et al. Association between plasma diacetylspermine and tumor spermine synthase with outcome in triple negative breast cancer. J. Natl. Cancer Inst.112(6), 607\u2013616. https:\/\/doi.org\/10.1093\/jnci\/djz182 (2020).","journal-title":"J. Natl. Cancer Inst."},{"key":"72938_CR28","doi-asserted-by":"publisher","first-page":"18757","DOI":"10.1074\/jbc.TM118.003336","volume":"293","author":"AS Bachmann","year":"2018","unstructured":"Bachmann, A. S. & Geerts, D. Polyamine synthesis as a target of MYC oncogenes. J. Biol. Chem.293, 18757\u201318769 (2018).","journal-title":"J. Biol. Chem."},{"key":"72938_CR29","doi-asserted-by":"publisher","unstructured":"Cancer Genome Atlas Research Network. Integrated genomic analyses of ovarian carcinoma. Nature. 474(7353):609\u2009\u2013\u200915. (2011). https:\/\/doi.org\/10.1038\/nature10166. Erratum in: Nature. 2012;490(7419):298.","DOI":"10.1038\/nature10166"},{"issue":"11","key":"72938_CR30","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1038\/s41568-018-0050-3","volume":"18","author":"RA Casero Jr","year":"2018","unstructured":"Casero, R. A. Jr, Murray Stewart, T. & Pegg, A. E. Polyamine metabolism and cancer: treatments, challenges and opportunities. Nat. Rev. Cancer. 18(11), 681\u2013695. https:\/\/doi.org\/10.1038\/s41568-018-0050-3 (2018). PMID: 30181570; PMCID: PMC6487480.","journal-title":"Nat. Rev. Cancer"},{"issue":"2","key":"72938_CR31","doi-asserted-by":"publisher","first-page":"CNS16","DOI":"10.2217\/cns-2017-0031","volume":"7","author":"VA Levin","year":"2018","unstructured":"Levin, V. A., Ictech, S. E. & Hess, K. R. Clinical importance of eflornithine (\u03b1-difluoromethylornithine) for the treatment of malignant gliomas. CNS Oncol.7(2), CNS16. https:\/\/doi.org\/10.2217\/cns-2017-0031 (2018).","journal-title":"CNS Oncol."},{"issue":"3","key":"72938_CR32","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1038\/bjc.2013.15","volume":"108","author":"KP Raj","year":"2013","unstructured":"Raj, K. P. et al. Role of dietary polyamines in a phase III clinical trial of difluoromethylornithine (DFMO) and sulindac for prevention of sporadic colorectal adenomas. Br. J. Cancer. 108(3), 512\u2013518. https:\/\/doi.org\/10.1038\/bjc.2013.15 (2013). Epub 2013 Jan 22. PMID: 23340449; PMCID: PMC3593561.","journal-title":"Br. J. Cancer"},{"issue":"22","key":"72938_CR33","doi-asserted-by":"publisher","first-page":"13938","DOI":"10.3390\/ijms232213938","volume":"23","author":"H Iwamoto","year":"2022","unstructured":"Iwamoto, H. et al. Metabolomic profiling of plasma, urine, and saliva of kidney transplantation recipients. Int. J. Mol. Sci.23(22), 13938. https:\/\/doi.org\/10.3390\/ijms232213938 (2022). PMID: 36430414; PMCID: PMC9695205.","journal-title":"Int. J. Mol. Sci."},{"key":"72938_CR34","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1007\/978-1-0716-2699-3_8","volume":"2571","author":"M Sugimoto","year":"2023","unstructured":"Sugimoto, M. & Aizawa, Y. Metabolomics analysis of blood, urine, and saliva samples based on capillary electrophoresis-mass spectrometry. Methods Mol Biol.2571, 83\u201394. https:\/\/doi.org\/10.1007\/978-1-0716-2699-3_8 (2023).","journal-title":"Methods Mol Biol."},{"issue":"1","key":"72938_CR35","doi-asserted-by":"publisher","first-page":"12075","DOI":"10.1038\/s41598-018-30482-x","volume":"8","author":"A Tomita","year":"2018","unstructured":"Tomita, A. et al. Effect of storage conditions on salivary polyamines quantified via liquid chromatography-mass spectrometry. Sci. Rep.8(1), 12075. https:\/\/doi.org\/10.1038\/s41598-018-30482-x (2018). PMID: 30104641; PMCID: PMC6089938.","journal-title":"Sci. Rep."},{"issue":"1","key":"72938_CR36","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1007\/s11306-009-0178-y","volume":"6","author":"M Sugimoto","year":"2010","unstructured":"Sugimoto, M., Wong, D. T., Hirayama, A., Soga, T. & Tomita, M. Capillary electrophoresis mass spectrometry-based saliva metabolomics identified oral, breast and pancreatic cancer-specific profiles. Metabolomics. 6(1), 78\u201395. https:\/\/doi.org\/10.1007\/s11306-009-0178-y (2010). Epub 2009 Sep 10. PMID: 20300169; PMCID: PMC2818837.","journal-title":"Metabolomics"},{"key":"72938_CR37","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1007\/978-1-0716-2699-3_21","volume":"2571","author":"M Sugimoto","year":"2023","unstructured":"Sugimoto, M., Aizawa, Y. & Tomita, A. Data processing and analysis in liquid chromatography-mass spectrometry-based targeted metabolomics. Methods Mol Biol.2571, 241\u2013255. https:\/\/doi.org\/10.1007\/978-1-0716-2699-3_21 (2023).","journal-title":"Methods Mol Biol."},{"issue":"W1","key":"72938_CR38","doi-asserted-by":"publisher","first-page":"W388","DOI":"10.1093\/nar\/gkab382","volume":"49","author":"Z Pang","year":"2021","unstructured":"Pang, Z. et al. MetaboAnalyst 5.0: Narrowing the gap between raw spectra and functional insights. Nucleic Acids Res.49(W1), W388\u2013W396. https:\/\/doi.org\/10.1093\/nar\/gkab382 (2021).","journal-title":"Nucleic Acids Res."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-72938-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-72938-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-72938-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,20]],"date-time":"2024-09-20T15:07:10Z","timestamp":1726844830000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-72938-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,16]]},"references-count":38,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["72938"],"URL":"https:\/\/doi.org\/10.1038\/s41598-024-72938-3","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,16]]},"assertion":[{"value":"25 January 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 September 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 September 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Masahiro Sugimoto received annual value of remuneration from Saliva Tech Co. Ldt. and Human Metabolome Technologies Inc. Masahiro Sugimoto and Makoto Sunamura received annual profit from share from Saliva Tech Co. Ldt. The other authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The study protocol was approved by the Ethics Committee of Yamagata University School of Medicine (2019\u2009\u2212\u2009385). All informed consent was obtained from each participant prior to participation in the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}],"article-number":"21555"}}